BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 16, 2021
View Archived Issues
Zeolitic imidazolate frameworks for sustained checkpoint inhibitor release in cancer immunotherapy
Read More
Preclinical results of an ACE2-interacting domain of SARS-CoV-2 peptide for COVID-19 treatment
Read More
Mucolipidosis type II AAV9 gene therapy demonstrates safety in wild-type mice
Read More
Interim phase I/II data show safety and systemic efficacy of RGX-121 in patients with MPS II
Read More
Sunshine Lake Pharma discovers teixobactin analogues
Read More
Preliminary phase II data for eganelisib plus nivolumab in advanced urothelial carcinoma
Read More
SIG-018 ameliorates symptoms of MPS II in preclinical models
Read More
New dihydroceramide desaturase inhibitors presented by Cincera Therapeutics
Read More
Dana-Farber Cancer Institute describes new CDK7/cyclin H inhibitors
Read More
New E-NPP 2 inhibitors identified at Boehringer Ingelheim
Read More
BeiGene patents MAP4K1 inhibitors
Read More
One-dose immunogenicity of BNT-162b2 vaccine among different groups of Israeli healthcare workers
Read More
Orchard Therapeutics reports data from trial of OTL-201 in MPS type III A
Read More
Multiorgan organoid gives developmental insights
Read More
First phase III data presented for nivolumab in patients with high-risk MIUC under radical surgery
Read More
FDA places partial clinical hold on atuzaginstat
Read More
Neuren reports phase I data on NNZ-2591 and plans to expand development into Prader-Willi syndrome
Read More
TLX-591-CDx for prostate cancer imaging receives first E.U. approval in Czech Republic
Read More
WHO lists two versions of AstraZeneca/Oxford COVID-19 vaccine for emergency use
Read More
Valbiotis gains French clearance to begin phase II study of TOTUM-070 to reduce LDL-cholesterol
Read More
InteRNA initiates first-in-human study of INT-1B3 in advanced solid tumors
Read More